Master Protocols and Adaptive Trial Designs to Develop Tumor-Agnostic Drugs for Children-Reference-Cited by-同舟云学术

Master Protocols and Adaptive Trial Designs to Develop Tumor-Agnostic Drugs for Children

Published:2021-09-01 Issue:9 Volume:7 Page:1281
ISSN:2374-2437
Container-title:JAMA Oncology
language:en
Short-container-title:JAMA Oncol

Author:

Arfè Andrea¹,Silverman Lewis B.²,Bourgeois Florence³⁴

Affiliation:

1. Harvard-MIT Center for Regulatory Science, Harvard Medical School, Boston, Massachusetts

2. Dana-Farber Cancer Institute/Boston Children’s Hospital, Boston, Massachusetts

3. Pediatric Therapeutics and Regulatory Science Initiative, Computational Health Informatics Program, Boston Children’s Hospital, Boston, Massachusetts

4. Department of Pediatrics, Harvard Medical School, Boston, Massachusetts

Publisher

American Medical Association (AMA)

Subject

Oncology,Cancer Research

Link

https://jamanetwork.com/journals/jamaoncology/articlepdf/2780586/jamaoncology_arf_2021_vp_210007_1631288496.48817.pdf

Reference9 articles.

1. Early phase pediatric cancer trials: progress highlights challenges.;Adamson;Oncologist,2020

2. Pediatric trials for cancer therapies with targets potentially relevant to pediatric cancers.;Hwang;J Natl Cancer Inst,2020

3. Cancer drugs approved for use in children: impact of legislative initiatives and future opportunities.;Barone;Pediatr Blood Cancer,2019

4. Accelerating pediatric cancer drug development: challenges and opportunities for pediatric master protocols.;Khan;Ther Innov Regul Sci,2019

5. The genomic landscape of pediatric cancers: implications for diagnosis and treatment.;Sweet-Cordero;Science,2019

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Timing for First-in-Minor Clinical Trials of New Cancer Drugs;The Journal of Pediatrics;2023-12

2. Clinical development of new drugs for adults and children with cancer, 2010-2020;JNCI: Journal of the National Cancer Institute;2023-05-12

3. Clinical trial considerations for pediatric cancer drug development;Journal of Biopharmaceutical Statistics;2023-02-07

4. Role of Precision Medicine in Pediatric Oncology;Pediatric Annals;2022-01